|
CIZ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.896600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.365800E-02 |
| Normal-vs-Stage2 |
9.005800E-01 |
| Normal-vs-Stage3 |
5.826600E-01 |
| Normal-vs-Stage4 |
4.261400E-01 |
| Stage1-vs-Stage2 |
1.685370E-01 |
| Stage1-vs-Stage3 |
5.926400E-02 |
| Stage1-vs-Stage4 |
2.671900E-02 |
| Stage2-vs-Stage3 |
6.046000E-01 |
| Stage2-vs-Stage4 |
3.792200E-01 |
| Stage3-vs-Stage4 |
6.589000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.581600E-01 |
| Normal-vs-AfricanAmerican |
3.567400E-01 |
| Normal-vs-Asian |
5.755200E-01 |
| Caucasian-vs-AfricanAmerican |
9.906600E-01 |
| Caucasian-vs-Asian |
6.588600E-01 |
| AfricanAmerican-vs-Asian |
6.272000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.393700E-02 |
| Normal-vs-Female |
4.662000E-01 |
| Male-vs-Female |
2.868100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.382600E-01 |
| Normal-vs-Extreme_Weight |
2.112200E-02 |
| Normal-vs-Obese |
5.637600E-01 |
| Normal-vs-Extreme_Obese |
2.311900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.150600E-01 |
| Normal_Weight-vs-Obese |
3.888600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.250800E-01 |
| Extreme_Weight-vs-Obese |
1.822460E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.624800E-01 |
| Obese-vs-Extreme_Obese |
1.098180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.806400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.779200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.306300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.851360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.196200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.588640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.106800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.273950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.012200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.276600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.009800E-01 |
| Normal-VS-Type2 PRCC |
4.090600E-01 |
| Normal-VS-KIRP CIMP |
1.247810E-01 |
| Normal-VS-Unclassified PRCC |
4.591200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.489800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.168200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.757000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.237640E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.251400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.415800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.459700E-02 |
| Normal-vs-N1 |
1.125610E-01 |
| Normal-vs-N2 |
8.497000E-01 |
| N0-vs-N1 |
1.283860E-02 |
| N0-vs-N2 |
5.165600E-01 |
| N1-vs-N2 |
4.516400E-01 |
|
|
